Short description
Pharmion engages in the acquisition, development, and commercialization of products for the treatment of hematology and oncology patients.
Description
Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. We work in partnership with a network of scientific and clinical advisors to identify and develop products for global hematology and oncology markets.
To expand each product's potential, we have established our own regulatory, development and sales and marketing organizations in the United States, Europe, and Australia, and we have developed a third-party distributor network to serve the hematology and oncology markets in 20 additional countries throughout the Middle East, Asia, and Latin America. The global capabilities within our sales, marketing and distribution organization distinguishes us from other companies of a similar size. With our international network we can reach physicians and their patients in more than 30 countries.
With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on licensing, developing, and commercializing therapeutic products for the treatment of hematology and oncology patients. Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients’ quality of life.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Boulder, Colorado, United States, North America
Founded on
January 1, 1999
Closed on
March 10, 2008
Exited on
November 6, 2003
Went public on
November 6, 2003
Delisted on
March 7, 2008
Stock symbol
PHRM
Non-profit?
No
Acquired?
No
Employees count
251-500
Investors
Blurry Noaccess, Cannot Access, Nopepepe, Nopepepe, Cannot Access, Noway Youcantaccess, Absolutely Noaccess, Noaccess, Absolutely Noaccess, Noway Youcantaccess, Uh Ohhhh
Sign in for full access